Imerys S.A.

IMYSF · OTC
Analyze with AI
6/30/2025
3/31/2025
12/31/2024
9/30/2024
Revenue$885,600$871,000$831,900$855,000
% Growth1.7%4.7%-2.7%
Cost of Goods Sold$617,700$0$596,000$0
Gross Profit$267,900$871,000$235,300$855,000
% Margin30.3%100%28.3%100%
R&D Expenses$0$0$0$0
G&A Expenses$0$0$0$0
SG&A Expenses$857,200$0$0$0
Sales & Mktg Exp.$0$0$0$0
Other Operating Expenses-$662,600$815,000$512,400$778,000
Operating Expenses$194,600$815,000$512,400$778,000
Operating Income$73,300$56,000-$38,500$77,000
% Margin8.3%6.4%-4.6%9%
Other Income/Exp. Net-$9,900-$22,000$75,000-$13,000
Pre-Tax Income$63,400$34,000$36,500$64,000
Tax Expense$15,900$11,000$306,600$23,000
Net Income$47,500$23,000$48,000-$285,000
% Margin5.4%2.6%5.8%-33.3%
EPS0.560.270.57-3.37
% Growth107.4%-52.6%116.9%
EPS Diluted0.560.270.57-3.37
Weighted Avg Shares Out84,72784,41484,64484,644
Weighted Avg Shares Out Dil84,61584,41484,64184,641
Supplemental Information
Interest Income$0$0$0$0
Interest Expense$12,200$15,000$0$12,000
Depreciation & Amortization$56,250$55,925$55,925$59,000
EBITDA$129,550$111,925$98,025$137,000
% Margin14.6%12.9%11.8%16%